Key result
Mobile health technologies, including ICDs and smartphone apps, offer potential for remote monitoring in cardiology, though implementation is impeded by unreliability and regulatory challenges.
While mobile health technologies and ICDs offer promising avenues for remote cardiology monitoring, significant regulatory, privacy, and reliability barriers must be addressed for widespread implementation.
Answers are grounded in this paper and cite their sources.
Barriers limit mobile health adoption in cardiology now; leaves open validation of reliability and regulation for remote monitoring.
INTRODUCTION: Recent developments in implantable cardioverter-defibrillators (ICDs) and smartphone technology have increased the possibilities for remote monitoring. It is the purpose of this review to give an overview of these new possibilities. AREAS COVERED: Remote monitoring in ICD allows for early detection of lead fractures and remote follow-up of patients. Possible limitations are the lack of standardization and the possible unsafety of the data stored on the ICD. Secondly, remote monitoring of health parameters using smartphone compatible wearables and smartphone medical apps is addressed. Possible limitations include the fact that the majority of smartphone apps are unregulated by the regulatory authorities and privacy issues such as selling of app-generated data to third parties. Lastly, clinical studies with smartphone apps are discussed. Expert commentary: New technologies in ICDs and smartphones have the potential to be used for remote monitoring. However, unreliability of smartphone technology, inadequate legislation and lack of reimbursement impede implementation.
No takes yet. Share an insight, caveat, or question.
Treskes et al. (2016) conducted a review in Cardiovascular disease. Mobile health and remote monitoring (ICDs, smartphone apps, wearables) was evaluated. Mobile health technologies, including ICDs and smartphone apps, offer potential for remote monitoring in cardiology, though implementation is impeded by unreliability and regulatory challenges.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: